Avera Pharmaceuticals: Clinical Trials

4 trials sponsored by Avera Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 12Completed 1, Terminated 1

Follow Avera Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
AV608 - Overactive Bladder Syndrome
Phase 2TerminatedAvera Pharmaceuticals622006-06-012008-02-25
Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
AV608 - Irritable Bowel Syndrome (IBS)
Phase 1TerminatedAvera Pharmaceuticals242006-04-012008-02-25
Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
AV608 - Social Phobia
Phase 2CompletedAvera Pharmaceuticals1802006-02-012008-02-25
The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia
Gantacurium Chloride for Injection (AV430A) - Healthy
Phase 1 / Phase 2CompletedAvera Pharmaceuticals2002005-05-012006-07-21

Conditions studied

Irritable Bowel Syndrome (1)  ·  Phobia, Social (1)  ·  Urinary Bladder, Overactive (1)  ·  Urinary Incontinence, Urge (1)

Interventions

Injections (1)

Countries

United States (2)  ·  Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Joao Siffert, MD (2)  ·  Jorgen Viby-Mogensen, MD (1)  ·  Kirsten Tillisch, MD (1)  ·  Linda Cardozo, MD FRCOG (1)  ·  Manfred Blobner, MD (1)